We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+11.99%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.96B
AUM Growth
+$565M
Cap. Flow
-$238M
Cap. Flow %
-2.66%
Top 10 Hldgs %
14.1%
Holding
748
New
26
Increased
189
Reduced
394
Closed
36

Top Buys

Rank Stock Value
1
STAG icon
STAG Industrial
STAG
+$26.5M
2
CRI icon
Carter's
CRI
+$23.3M
3
HWC icon
Hancock Whitney
HWC
+$19.5M
4
UL icon
Unilever
UL
+$16.7M
5
MTDR icon
Matador Resources
MTDR
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.98%
2 Industrials 16.66%
3 Technology 16.47%
4 Financials 13.37%
5 Consumer Discretionary 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBTM
276
JBT Marel
JBTM
$7.41B
$6.94M 0.08%
76,008
+5,223
+7% +$478K
ICE icon
277
Intercontinental Exchange
ICE
$85.2B
$6.93M 0.08%
67,596
-1,565
-2% -$156K
EFOR
278
Everforth Inc
EFOR
$1.22B
$6.87M 0.08%
84,335
+5,837
+7% +$512K
BOX icon
279
Box
BOX
$4.39B
$6.75M 0.08%
+216,952
New +$6.19M
PHR icon
280
Phreesia
PHR
$698M
$6.64M 0.07%
205,184
-23,433
-10% -$636K
ANGO icon
281
AngioDynamics
ANGO
$627M
$6.63M 0.07%
481,641
-4,299
-0.9% -$59.8K
BWXT icon
282
BWX Technologies
BWXT
$15.9B
$6.56M 0.07%
112,953
-20,572
-15% -$1.18M
HUN icon
283
Huntsman Corp
HUN
$1.76B
$6.41M 0.07%
233,435
-44,214
-16% -$1.2M
EMR icon
284
Emerson Electric
EMR
$86.7B
$6.41M 0.07%
66,745
+50
+0.1% +$4.5K
DEN
285
DELISTED
Denbury Inc.
DEN
$6.39M 0.07%
+73,416
New +$6.67M
QQQ icon
286
Invesco QQQ Trust
QQQ
$469B
$6.27M 0.07%
23,541
-1,619
-6% -$448K
VCYT icon
287
Veracyte
VCYT
$3.61B
$6.24M 0.07%
263,152
-30,933
-11% -$719K
IEX icon
288
IDEX
IEX
$17.2B
$6.17M 0.07%
27,034
-783
-3% -$175K
AZTA icon
289
Azenta
AZTA
$1.38B
$6.16M 0.07%
105,867
+64,680
+157% +$3.31M
WAL icon
290
Western Alliance Bancorporation
WAL
$9.04B
$6.05M 0.07%
101,610
-41,573
-29% -$2.69M
IPAR icon
291
Interparfums
IPAR
$4B
$6M 0.07%
62,155
+362
+0.6% +$31.4K
BMY icon
292
Bristol-Myers Squibb
BMY
$134B
$5.93M 0.07%
82,469
+200
+0.2% +$15.1K
AVNT icon
293
Avient
AVNT
$3.43B
$5.92M 0.07%
175,354
+12,134
+7% +$399K
SSD icon
294
Simpson Manufacturing
SSD
$7.91B
$5.89M 0.07%
+66,397
New +$5.8M
CBZ icon
295
CBIZ
CBZ
$2.99B
$5.88M 0.07%
+125,474
New +$5.96M
EVBG
296
DELISTED
Everbridge, Inc. Common Stock
EVBG
$5.81M 0.06%
196,328
-2,503
-1% -$76.7K
SITE icon
297
SiteOne Landscape Supply
SITE
$4.33B
$5.81M 0.06%
49,490
+3,440
+7% +$401K
ONT
298
Onterris Inc
ONT
$795M
$5.79M 0.06%
130,539
+9,047
+7% +$383K
QQEW icon
299
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.77B
$5.79M 0.06%
65,263
+938
+1% +$83.8K
GSHD icon
300
Goosehead Insurance
GSHD
$2.33B
$5.75M 0.06%
167,389
+11,602
+7% +$435K

Similar funds

Segall Bryant & Hamill's Q4 2022 Portfolio in Review

As of Q4 2022, Segall Bryant & Hamill held 748 positions worth $8.96B, up 6.7% from $8.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Segall Bryant & Hamill's Q4 2022 filing shows 26 new, 189 increased, 394 reduced and 36 closed positions. Its largest new stake was STAG Industrial: 847,354 shares worth $27.4M. The largest sale was CATALENT, INC., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

  • Segall Bryant & Hamill's largest Q4 2022 buy was STAG Industrial: 847,354 shares worth $27.4M.
  • Segall Bryant & Hamill added most to Hancock Whitney in Q4 2022, an estimated $19.5M increase.
  • Segall Bryant & Hamill's biggest Q4 2022 reduction was CATALENT, INC., cutting an estimated $32.8M.
  • Segall Bryant & Hamill fully exited Avalara, Inc. in Q4 2022, selling an estimated $10.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 14% of its $8.96B portfolio in Q4 2022.
  • Segall Bryant & Hamill opened 26 new positions and closed 36 in Q4 2022.
  • Segall Bryant & Hamill's portfolio value rose 6.7% quarter-over-quarter to $8.96B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2022, filed 14 Feb 2023.